Yüklüyor......
Fixed‐dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia
Hypertension and dyslipidemia are important risk factors for cardiovascular disease. However, the clinical outcomes of fixed‐dose combination (FDC) versus free‐equivalent combination (FEC) of amlodipine and atorvastatin in the treatment of concurrent hypertension and dyslipidemia remain unknown. In...
Kaydedildi:
| Yayımlandı: | J Clin Hypertens (Greenwich) |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8029959/ https://ncbi.nlm.nih.gov/pubmed/32862551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.14016 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|